List of Contents

Intravenous Immunoglobulin Market Size, Share, and Trends 2024 to 2034

Intravenous Immunoglobulin Market (By Product: IGG, IGA, IGM, IGE, IGD; By Route of Administration: Intravenous, Subcutaneous; By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy, Immunodeficiency diseases, Myasthenia Gravis, Multifocal motor neuropathy, Idiopathic thrombocytopenic purpura, Inflammatory myopathies, Others; By End-Users; By Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034

  • Last Updated : July 2024
  • Report Code : 2996
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Intravenous Immunoglobulin Market 

5.1. COVID-19 Landscape: Intravenous Immunoglobulin Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Intravenous Immunoglobulin Market, By Product

8.1. Intravenous Immunoglobulin Market Revenue and Volume, by Product, 2024-2034

8.1.1. IGG

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. IGA

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. IGM

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

8.1.4. IGE

8.1.4.1. Market Revenue and Volume Forecast (2021-2034)

8.1.5. IGD

8.1.5.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Intravenous Immunoglobulin Market, By Route of Administration

9.1. Intravenous Immunoglobulin Market Revenue and Volume, by Route of Administration, 2024-2034

9.1.1. Intravenous

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Subcutaneous

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Intravenous Immunoglobulin Market, By Application 

10.1. Intravenous Immunoglobulin Market Revenue and Volume, by Application, 2024-2034

10.1.1. Hypogammaglobulinemia

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Chronic Inflammatory demyelinating polyneuropathy (CIDP)

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Immunodeficiency diseases

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

10.1.4. Myasthenia Gravis

10.1.4.1. Market Revenue and Volume Forecast (2021-2034)

10.1.5. Multifocal motor neuropathy

10.1.5.1. Market Revenue and Volume Forecast (2021-2034)

10.1.6. Idiopathic thrombocytopenic purpura (ITP)

10.1.6.1. Market Revenue and Volume Forecast (2021-2034)

10.1.7. Inflammatory myopathies

10.1.7.1. Market Revenue and Volume Forecast (2021-2034)

10.1.8. Specific antibody deficiency

10.1.8.1. Market Revenue and Volume Forecast (2021-2034)

10.1.9. Guillain-Barre syndrome

10.1.9.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Intravenous Immunoglobulin Market, By End-Users

11.1. Intravenous Immunoglobulin Market Revenue and Volume, by End-Users, 2024-2034

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Homecare

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

11.1.3. Specialty Clinics

11.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Intravenous Immunoglobulin Market, By Distribution Channel

12.1. Intravenous Immunoglobulin Market Revenue and Volume, by Distribution Channel, 2024-2034

12.1.1. Hospital Pharmacy

12.1.1.1. Market Revenue and Volume Forecast (2021-2034)

12.1.2. Retail Pharmacy

12.1.2.1. Market Revenue and Volume Forecast (2021-2034)

12.1.3. Online Pharmacies

12.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 13. Global Intravenous Immunoglobulin Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.1.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.1.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.6.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.6.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.1.7.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.1.7.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.1.7.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.2.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.4. Market Revenue and Volume Forecast, by End-Users (2021-2034) 

13.2.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034) 

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.6.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.7. Market Revenue and Volume Forecast, by End-Users (2021-2034) 

13.2.8. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034) 

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.9.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.2.9.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.10. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.2.11. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.12.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.2.12.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.12.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.2.13. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.2.14.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.2.14.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.2.14.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.2.15. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.3.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.3.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.6.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.6.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.3.7. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.8.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.8.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.3.9. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.10.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.3.10.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.10.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.3.11.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.3.11.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.3.11.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.4.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.4.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.6.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.6.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.4.7. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.8.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.8.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.4.9. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.10.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.4.10.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.10.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.4.11.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.4.11.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.4.11.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.5.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.5.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.6.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.6.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.5.7. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

13.5.8.2. Market Revenue and Volume Forecast, by Route of Administration (2021-2034)

13.5.8.3. Market Revenue and Volume Forecast, by Application (2021-2034)

13.5.8.4. Market Revenue and Volume Forecast, by End-Users (2021-2034)

13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

Chapter 14. Company Profiles

14.1. Biotest AG

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Octapharma AG

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. LFB Biotechnologies

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Grifols SA

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. CSL Behring

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. China Biologics Products Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Kedrion Biopharma

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. BDI Pharma Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us